VTRS Q2 2019 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.9B+1.5% YoY

Gross Profit

$933M32.7% margin

Operating Income

$96M3.3% margin

Net Income

-$169M-5.9% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+14.3%

Cash Flow

Operating Cash Flow

$669M

Free Cash Flow

$625M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$31.8B

Total Liabilities

$19.9B

Stockholders' Equity

$11.9B

Cash & Equivalents

$212M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.9B	$2.8B	+1.5%
Gross Profit	$933M	$963M	-3.1%
Operating Income	$96M	$179M	-46.6%
Net Income	-$169M	$38M	-549.3%